##gff-version 3
##sequence-region Q8IVT2 1 679
Q8IVT2	UniProtKB	Chain	1	679	.	.	.	ID=PRO_0000079381;Note=Mitotic interactor and substrate of PLK1	
Q8IVT2	UniProtKB	Coiled coil	545	569	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8IVT2	UniProtKB	Modified residue	78	78	.	.	.	Note=Phosphoserine%3B by CDK1%3B in vitro;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:23509069;Dbxref=PMID:20068231,PMID:23186163,PMID:23509069	
Q8IVT2	UniProtKB	Modified residue	156	156	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8IVT2	UniProtKB	Modified residue	164	164	.	.	.	Note=Phosphothreonine%3B by CDK1%3B in vitro;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18220336,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:23509069;Dbxref=PMID:18220336,PMID:18669648,PMID:20068231,PMID:23186163,PMID:23509069	
Q8IVT2	UniProtKB	Modified residue	172	172	.	.	.	Note=Phosphothreonine%3B by CDK1%3B in vitro;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000269|PubMed:23509069;Dbxref=PMID:18669648,PMID:23509069	
Q8IVT2	UniProtKB	Modified residue	179	179	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8IVT2	UniProtKB	Modified residue	214	214	.	.	.	Note=Phosphoserine%3B by CDK1%3B in vitro;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:20068231,ECO:0000269|PubMed:23509069;Dbxref=PMID:20068231,PMID:23509069	
Q8IVT2	UniProtKB	Modified residue	219	219	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231;Dbxref=PMID:18669648,PMID:20068231	
Q8IVT2	UniProtKB	Modified residue	224	224	.	.	.	Note=Phosphothreonine%3B by CDK1%3B in vitro;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:23509069;Dbxref=PMID:18669648,PMID:23186163,PMID:23509069	
Q8IVT2	UniProtKB	Modified residue	284	284	.	.	.	Note=Phosphoserine%3B by CDK1%3B in vitro;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:18691976,ECO:0000269|PubMed:23509069;Dbxref=PMID:18669648,PMID:18691976,PMID:23509069	
Q8IVT2	UniProtKB	Modified residue	287	287	.	.	.	Note=Phosphothreonine%3B by CDK1%3B in vitro;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:20068231,ECO:0000269|PubMed:23509069;Dbxref=PMID:18669648,PMID:18691976,PMID:20068231,PMID:23509069	
Q8IVT2	UniProtKB	Modified residue	348	348	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8IVT2	UniProtKB	Modified residue	377	377	.	.	.	Note=Phosphothreonine%3B by CDK1%3B in vitro;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:20068231,ECO:0000269|PubMed:23509069;Dbxref=PMID:20068231,PMID:23509069	
Q8IVT2	UniProtKB	Modified residue	382	382	.	.	.	Note=Phosphoserine%3B by CDK1%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Modified residue	394	394	.	.	.	Note=Phosphoserine%3B by PLK1%3B in vitro;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:23509069;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163,PMID:23509069	
Q8IVT2	UniProtKB	Modified residue	395	395	.	.	.	Note=Phosphoserine%3B by PLK1%3B in vitro;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:23509069;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163,PMID:23509069	
Q8IVT2	UniProtKB	Modified residue	397	397	.	.	.	Note=Phosphoserine%3B by PLK1%3B in vitro;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:23509069;Dbxref=PMID:18669648,PMID:23186163,PMID:23509069	
Q8IVT2	UniProtKB	Modified residue	400	400	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:18691976,PMID:20068231,PMID:23186163	
Q8IVT2	UniProtKB	Modified residue	430	430	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q8IVT2	UniProtKB	Modified residue	471	471	.	.	.	Note=Phosphoserine%3B by PLK1%3B in vitro;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:23186163	
Q8IVT2	UniProtKB	Modified residue	541	541	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163	
Q8IVT2	UniProtKB	Modified residue	543	543	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q8IVT2	UniProtKB	Modified residue	575	575	.	.	.	Note=Phosphoserine%3B by CDK1%3B in vitro;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:23509069;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163,PMID:23509069	
Q8IVT2	UniProtKB	Modified residue	577	577	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231;Dbxref=PMID:18669648,PMID:20068231	
Q8IVT2	UniProtKB	Modified residue	582	582	.	.	.	Note=Phosphoserine%3B by PLK1%3B in vitro;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000269|PubMed:23509069;Dbxref=PMID:18669648,PMID:20068231,PMID:23509069	
Q8IVT2	UniProtKB	Modified residue	586	586	.	.	.	Note=Phosphoserine%3B by PLK1%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Modified residue	675	675	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q8IVT2	UniProtKB	Natural variant	99	99	.	.	.	ID=VAR_061629;Note=A->T;Dbxref=dbSNP:rs45477999	
Q8IVT2	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_033754;Note=S->G;Dbxref=dbSNP:rs3746173	
Q8IVT2	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_033755;Note=K->R;Dbxref=dbSNP:rs3746175	
Q8IVT2	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_050910;Note=S->N;Dbxref=dbSNP:rs35384259	
Q8IVT2	UniProtKB	Natural variant	653	653	.	.	.	ID=VAR_033756;Note=E->G;Dbxref=dbSNP:rs8107847	
Q8IVT2	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Almost complete loss of CDK1 phosphorylation in vitro%2C loss of PLK1-binding%2C no effect on cortical localization%3B when associated with A-164%3B A-172%3B A-214%3B A-224%3B A-284%3B A-287%3B A-377 and A-575. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Almost complete loss of CDK1 phosphorylation in vitro%2C loss of PLK1-binding%2C no effect on cortical localization%3B when associated with A-78%3B A-172%3B A-214%3B A-224%3B A-284%3B A-287%3B A-377 and A-575. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	172	172	.	.	.	Note=Almost complete loss of CDK1 phosphorylation in vitro%2C loss of PLK1-binding%2C no effect on cortical localization%3B when associated with A-78%3B A-164%3B A-214%3B A-224%3B A-284%3B A-287%3B A-377 and A-575. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	214	214	.	.	.	Note=Almost complete loss of CDK1 phosphorylation in vitro%2C loss of PLK1-binding%2C no effect on cortical localization%3B when associated with A-78%3B A-164%3B A-172%3B A-224%3B A-284%3B A-287%3B A-377 and A-575. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	224	224	.	.	.	Note=Almost complete loss of CDK1 phosphorylation in vitro%2C loss of PLK1-binding%2C no effect on cortical localization%3B when associated with A-78%3B A-164%3B A-172%3B A-214%3B A-284%3B A-287%3B A-377 and A-575. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	284	284	.	.	.	Note=Almost complete loss of CDK1 phosphorylation in vitro%2C loss of PLK1-binding%2C no effect on cortical localization%3B when associated with A-78%3B A-164%3B A-172%3B A-214%3B A-224%3B A-287%3B A-377 and A-575. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	287	287	.	.	.	Note=Almost complete loss of CDK1 phosphorylation in vitro%2C loss of PLK1-binding%2C no effect on cortical localization%3B when associated with A-78%3B A-164%3B A-172%3B A-214%3B A-224%3B A-284%3B A-377 and A-575. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	377	377	.	.	.	Note=Almost complete loss of CDK1 phosphorylation in vitro%2C loss of PLK1-binding%2C no effect on cortical localization%3B when associated with A-78%3B A-164%3B A-172%3B A-214%3B A-224%3B A-284%3B A-287 and A-575. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	382	382	.	.	.	Note=Almost complete loss of CDK1 phosphorylation in vitro%2C loss of PLK1-binding%2C no effect on cortical localization%3B when associated with A-394%3B A-395%3B A-397%3B A-471%3B A-582 and A-586. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	394	394	.	.	.	Note=Drastic reduction in PLK1 phosphorylation in vitro%2C no effect on cortical localization%3B when associated with A-382%3B A-395%3B A-397%3B A-471%3B A-582 and A-586. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	394	394	.	.	.	Note=No effect on cortical localization%3B when associated with D-395%3B D-397%3B D-471%3B D-582 and D-586. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	395	395	.	.	.	Note=Drastic reduction in PLK1 phosphorylation in vitro%2C no effect on cortical localization%3B when associated with A-382%3B A-394%3B A-397%3B A-471%3B A-582 and A-586. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	395	395	.	.	.	Note=No effect on cortical localization%3B when associated with D-394%3B D-397%3B D-471%3B D-582 and D-586. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	397	397	.	.	.	Note=Drastic reduction in PLK1 phosphorylation in vitro%2C no effect on cortical localization%3B when associated with A-382%3B A-394%3B A-395%3B A-471%3B A-582 and A-586. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	397	397	.	.	.	Note=No effect on cortical localization%3B when associated with D-394%3B D-395%3B D-471%3B D-582 and D-586. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	471	471	.	.	.	Note=Drastic reduction in PLK1 phosphorylation in vitro%2C no effect on cortical localization%3B when associated with A-382%3B A-394%3B A-395%3B A-397%3B A-582 and A-586. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	471	471	.	.	.	Note=No effect on cortical localization%3B when associated with D-394%3B D-395%3B D-397%3B D-582 and D-586. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	575	575	.	.	.	Note=Almost complete loss of CDK1 phosphorylation in vitro%2C loss of PLK1-binding%2C no effect on cortical localization%3B when associated with A-78%3B A-164%3B A-172%3B A-214%3B A-224%3B A-284%3B A-287 and A-377. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	582	582	.	.	.	Note=Drastic reduction in PLK1 phosphorylation in vitro%2C no effect on cortical localization%3B when associated with A-382%3B A-394%3B A-395%3B A-397%3B A-471 and A-586. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	582	582	.	.	.	Note=No effect on cortical localization%3B when associated with D-394%3B D-395%3B D-397%3B D-471 and D-586. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	586	586	.	.	.	Note=Drastic reduction in PLK1 phosphorylation in vitro%2C no effect on cortical localization%3B when associated with A-382%3B A-394%3B A-395%3B A-397%3B A-471 and A-582. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
Q8IVT2	UniProtKB	Mutagenesis	586	586	.	.	.	Note=No effect on cortical localization%3B when associated with D-394%3B D-395%3B D-397%3B D-471 and D-582. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23509069;Dbxref=PMID:23509069	
